Skip to main content
SpringerLink
Log in

Dutasteride, finasteride: no increased risk of ED

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wilcox Hagberg K, et al. Risk of erectile dysfunction associated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink. BMJ 2016: No. 354, 22 Sep 2016. Available from: URL: http://dx.doi.org/10.1136/bmj.i4823

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dutasteride, finasteride: no increased risk of ED. Reactions Weekly 1621, 10 (2016). https://doi.org/10.1007/s40278-016-21563-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-21563-2

Search

Navigation